Curis, Inc.
CRIS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.05 | -0.04 | 0.50 |
| FCF Yield | -205.02% | -56.95% | -106.59% | -8.63% |
| EV / EBITDA | -0.05 | -0.97 | -0.69 | -9.82 |
| Quality | ||||
| ROIC | -188.95% | -85.44% | -53.03% | -28.13% |
| Gross Margin | 99.10% | 97.88% | 97.47% | 94.99% |
| Cash Conversion Ratio | 0.91 | 0.81 | 0.96 | 0.83 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.39% | -2.00% | -2.11% | 2.10% |
| Free Cash Flow Growth | -2.94% | 29.80% | -45.55% | -42.41% |
| Safety | ||||
| Net Debt / EBITDA | 0.40 | 0.53 | 0.30 | 0.86 |
| Interest Coverage | -72.43 | -23.94 | -11.11 | -9.41 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -11,150.79 | -5,359.48 | -4,427.95 | -4,283.88 |